August 21, 2020 – Russell Reynolds Associates has assisted in the placement of world-renowned tumor immunologist Patrick Hwu as the new president and CEO of Moffitt Cancer Center in Tampa, FL. He begins his new role at Moffitt on Nov. 10.
“Dr. Hwu is truly a cancer visionary ready to elevate Moffitt to even greater success,” said Tim Adams, chair of Moffitt’s Institute board of directors. “Drawing from his innovative cancer research, quality patient care and extensive leadership experience, Dr. Hwu will no doubt continue to help Moffitt in our pursuit of dynamic growth and groundbreaking work.”
“Dr. Patrick Hwu is a nationally respected physician-scientist with the vision to lead Moffitt into the future,” said H. Lee Moffitt, founder. “Coming from the largest cancer center in the country, where he has distinguished himself and produced incredible results, we expect he will successfully guide the Moffitt team through the next generation of cancer treatments and discoveries.”
“I’m confident Dr. Hwu will inspire and continue our mission to contribute to the prevention and cure of cancer,” he said. “Our impact on helping cancer patients will be felt worldwide and, in the process, continue to make Florida proud.”
Dr. Hwu brings 33 years of oncology experience to Moffitt and is the division head of cancer medicine at the University of Texas MD Anderson Cancer Center. He held various leadership roles during 17 years at MD Anderson, including chair of the department of sarcoma medical oncology and co-director of the Center for Cancer Immunology Research. He was the first chair of the department of melanoma medical oncology. Known for leading transformative research into the clinic, Dr. Hwu helped pioneer the field of gene modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. His work focuses on vaccines, adoptive T-cell therapies and immune resistance. He is the principal investigator on a National Institutes of Health SPORE grant for melanoma and has more than 270 peer-reviewed publications.
“It is my distinct honor and privilege to be selected as the next president and CEO of Moffitt Cancer Center, which has made unprecedented strides in its 34 years in the prevention and treatment of cancer,” Dr. Hwu said. “I look forward to bringing my years of experience as a cancer physician, researcher and leader to help advance the outstanding work already underway by the teams of cancer experts at Florida’s top-ranked cancer hospital. I’m confident that our collective efforts will further elevate Moffitt’s leadership in cancer patient care, research and education.”
Moffitt’s mission is to “contribute to the prevention and cure of cancer.” The non-profit facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. With more than 7,000 team members, Moffitt has an economic impact in the state of Florida of $2.4 billion.
Russell Reynolds Associates’ public sector, trade and associations practice group serves a wide variety of public sector and not-for-profit organizations, related public bodies, regulators and government-owned companies. It also fills the executive leadership needs of global charities, healthcare providers, and local government and trade associations.
The firm also conducts in-depth organizational culture assessment and measures the cultural fit of key leadership and candidates in the following areas: arts and culture, global development, higher education, non-profit health and human services, public sector, social justice and advocacy, as well as trade and professional associations.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media